PT837699E - Imunovectores utilizaveis para o transporte intracelular e intranuclear - Google Patents

Imunovectores utilizaveis para o transporte intracelular e intranuclear

Info

Publication number
PT837699E
PT837699E PT96924965T PT96924965T PT837699E PT 837699 E PT837699 E PT 837699E PT 96924965 T PT96924965 T PT 96924965T PT 96924965 T PT96924965 T PT 96924965T PT 837699 E PT837699 E PT 837699E
Authority
PT
Portugal
Prior art keywords
imunovectors
intracellular
biologically active
active principle
cell
Prior art date
Application number
PT96924965T
Other languages
English (en)
Inventor
Stratis Avrameas
Gerard Buttin
Therese Ternynck
Faridabano Nato
Original Assignee
Pasteur Institut
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Univ Paris Curie filed Critical Pasteur Institut
Publication of PT837699E publication Critical patent/PT837699E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT96924965T 1995-07-10 1996-07-10 Imunovectores utilizaveis para o transporte intracelular e intranuclear PT837699E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9508316A FR2736642B1 (fr) 1995-07-10 1995-07-10 Immunovecteurs, notamment anticorps et fragments d'anticorps utilisables pour le transport intracellulaire et intranucleaire de principes biologiquement actifs notamment d'haptenes, de proteines et d'acides nucleiques

Publications (1)

Publication Number Publication Date
PT837699E true PT837699E (pt) 2003-09-30

Family

ID=9480845

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96924965T PT837699E (pt) 1995-07-10 1996-07-10 Imunovectores utilizaveis para o transporte intracelular e intranuclear

Country Status (11)

Country Link
US (3) US6608034B1 (pt)
EP (1) EP0837699B1 (pt)
JP (3) JP2000506361A (pt)
AT (1) ATE240746T1 (pt)
CA (1) CA2224413C (pt)
DE (1) DE69628298T2 (pt)
DK (1) DK0837699T3 (pt)
ES (1) ES2198495T3 (pt)
FR (1) FR2736642B1 (pt)
PT (1) PT837699E (pt)
WO (1) WO1997002840A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2736642B1 (fr) * 1995-07-10 1997-09-12 Pasteur Institut Immunovecteurs, notamment anticorps et fragments d'anticorps utilisables pour le transport intracellulaire et intranucleaire de principes biologiquement actifs notamment d'haptenes, de proteines et d'acides nucleiques
FR2766826B1 (fr) 1997-08-04 2001-05-18 Pasteur Institut Vecteurs derives d'anticorps pour le transfert de substances dans les cellules
EP1006197A1 (en) * 1998-12-04 2000-06-07 Transgene S.A. Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
JP3513068B2 (ja) * 1999-05-12 2004-03-31 浜松ホトニクス株式会社 生細胞の細胞質内標的核酸を検出する方法
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
FR2805821B1 (fr) 2000-03-01 2004-01-16 Diatos Sequences d'acides amines facilitant la penetration d'une substance d'interet a l'interieur des cellules et/ou des noyaux cellulaires
US20030032597A1 (en) * 2001-07-31 2003-02-13 Sebestyen Magdolna G. Targeting nucleic acids to a cellular nucleus
US7049286B2 (en) 2001-08-30 2006-05-23 Diatos, S.A. Insulin conjugates and methods of use thereof
US20060233790A1 (en) * 2002-03-22 2006-10-19 Shiroh Futaki Immunoglobulin/hydrophilic peptide complexes
WO2005016960A2 (en) 2003-08-14 2005-02-24 Diatos Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
EP1797901A1 (en) 2005-12-16 2007-06-20 Diatos Cell penetrating peptide conjugates for delivering nucleic acids into cells
EP1818395A1 (en) 2006-02-08 2007-08-15 Diatos Compositions and methods for treating lysosomal storage diseases
PT2748182T (pt) 2011-08-23 2017-01-20 Harvard College Nanopartículas peptídicas e utilizações das mesmas
EP2919808B1 (en) 2012-11-16 2020-07-29 United Biomedical, Inc. Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd)
JPWO2020250940A1 (pt) * 2019-06-11 2020-12-17

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334107A1 (fr) * 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
US4599998A (en) * 1984-06-01 1986-07-15 Castillo James D Adjustable polycentric orthopedic appliance hinge
US4812397A (en) * 1987-02-10 1989-03-14 The Regents Of The University Of California MAB-anti-DNA related to nephritis
US5428132A (en) * 1987-10-11 1995-06-27 United States Of America Conjugate and method for integration of foreign DNA into cells
US4952499A (en) * 1988-02-11 1990-08-28 Dana-Farber Cancer Institute Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses
US5391723A (en) * 1989-05-31 1995-02-21 Neorx Corporation Oligonucleotide conjugates
ZA914625B (en) * 1990-06-22 1993-02-24 Lilly Co Eli In vivo targeting with bifunctional antibodies
US5733523A (en) * 1990-12-10 1998-03-31 Akzo Nobel N.V. Targeted delivery of a therapeutic entity using complementary oligonucleotides
DE4104186A1 (de) * 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
WO1992019973A1 (en) * 1991-04-26 1992-11-12 Surface Active Limited Novel antibodies, and methods for their use
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5922859A (en) 1992-02-01 1999-07-13 Boehringer Ingelheim International Gmbh Complexes containing nucleic acid which can be taken-up by endocytosis into higher eukaryotic cells
WO1994004690A1 (en) * 1992-08-17 1994-03-03 Genentech, Inc. Bispecific immunoadhesins
DE4318402A1 (de) * 1993-06-03 1994-12-08 Boehringer Mannheim Gmbh Verfahren zum Nachweis eines programmierten oder induzierten Zelltods eukaryontischer Zeller
US5681700A (en) * 1994-05-25 1997-10-28 Oklahoma Medical Research Foundation Assay for pathogenicity of anti-DNA antibodies
US5648219A (en) * 1995-06-07 1997-07-15 Zymogenetics, Inc. Immortalized dendritic cells
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US5908777A (en) * 1995-06-23 1999-06-01 University Of Pittsburgh Lipidic vector for nucleic acid delivery
FR2736642B1 (fr) * 1995-07-10 1997-09-12 Pasteur Institut Immunovecteurs, notamment anticorps et fragments d'anticorps utilisables pour le transport intracellulaire et intranucleaire de principes biologiquement actifs notamment d'haptenes, de proteines et d'acides nucleiques
US5616819A (en) * 1995-08-28 1997-04-01 Laroche Industries Inc. Process for preparing fluorinated aliphatic compounds
JP2000507225A (ja) * 1996-03-08 2000-06-13 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア ｍａｂ ３Ｅ１０ ならびにその突然変異体および／または機能性フラグメントを使用する送達システム
US5992859A (en) * 1998-04-27 1999-11-30 Chum Power Machinery Corp. Bit holding system for a power hand tool

Also Published As

Publication number Publication date
FR2736642B1 (fr) 1997-09-12
DE69628298T2 (de) 2004-03-25
CA2224413A1 (fr) 1997-01-30
DK0837699T3 (da) 2003-09-22
ES2198495T3 (es) 2004-02-01
JP4680968B2 (ja) 2011-05-11
ATE240746T1 (de) 2003-06-15
JP2008054684A (ja) 2008-03-13
EP0837699A1 (fr) 1998-04-29
EP0837699B1 (fr) 2003-05-21
JP2000506361A (ja) 2000-05-30
US6608034B1 (en) 2003-08-19
US20040259822A1 (en) 2004-12-23
DE69628298D1 (de) 2003-06-26
FR2736642A1 (fr) 1997-01-17
CA2224413C (fr) 2009-10-13
WO1997002840A1 (fr) 1997-01-30
JP2010115202A (ja) 2010-05-27
US20110020928A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
PT837699E (pt) Imunovectores utilizaveis para o transporte intracelular e intranuclear
PT799058E (pt) Melhoramentos na funcao endometrica ou com ela relacionados
WO2002043477A1 (en) Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
MY137300A (en) Chimeric proteins for use in transport of a selected substance into cells
TR200101585T2 (tr) Multi-antijenler ve/veya antikorların in vitro bulgulanması için işlem ve aygıt.
EP0522169A4 (en) Antihuman stromelysin monoclonal antibody and diagnosis of rheumatoid arthritis by enzyme immunoassay
ATE260115T1 (de) Reduzierte fett-absorption durch anti-lipase antikörper
EP1254210A4 (en) METHOD FOR CLONING ANIMALS WITH TARGETED GENETIC CHANGES BY TRANSFER OF MALE OR FEMALE SOMATIC CELL CORES FROM LONG-TERM CULTURE INCLUDING ARTIFICIALLY INDUCED GENETIC CHANGES IN CORE RECEIVERS
EP1359161A3 (en) Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof
SI1115746T1 (sl) Protitelesa proti antigenu sesalskih Langerhansovih celic in njihova uporaba
DE69430313D1 (de) Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
BR9707134A (pt) Método e uso de polipetìdeo em ligação de esperma e ovo para aumentar ou diminuir a fertilidade.
EP0260599A3 (en) Method and agent for detecting antibodies against human and animal retroviruses, especially t-lymphotropic viruses
PT83368B (pt) Processo para a propagacao de microrganismos in vivo mediante utilizacao de linhas de celulas que nao contem antigenios da classe ii do complexo histocompatibilidade
ES2107545T3 (es) Anticuerpos policlonales dirigidos contra la hirudina y su utilizacion para la identificacion, la purificacion inmunologica y la determinacion cuantitativa de la hirudina.
Kippen et al. COMPTEL Locations of Gamma-Ray Bursts
Zverev et al. Geodetic maintenance of observations in the mm-wavelength range with the RATAN-600 radiotelescope.
Takahashi International VLBI experiments at the Communications Research Laboratory
Rakhimov et al. On the mutual position of the mass center and the center of the figure of the lunar limb zone.
Germogenova et al. Complex" RADUGA-4" for a numerical solution of the transfer equation of polarized radiation in axially symmetric media.
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2
Morikawa et al. Development of a New Position Sensitive Detector and its Application to Secondary Beam Coulex
SE9900134D0 (sv) A method for introducing substances into cells, and use of said method
Hajian et al. Sub-Arcsecond lambda 6 CM Images of PNe and their Expansion Parallax Distances
Vansant et al. Variable-Cell-Shape Molecular Dynamics applied to Ternary Calcium Nitrides.